For two decades, the longevity field was dominated by caloric restriction and telomere length. A generation of researchers staked careers on theories that have since crumbled under better data. What's replaced them is stranger, more promising, and considerably more complicated.
The FDA has not yet issued formal guidance. Researchers are divided. The practice is already widespread.
The origins of the figure, what population studies actually show, and what chronobiologists recommend instead.
$5.2 billion entered the space in 2025. Not all of it will survive contact with clinical reality.
New imaging techniques are revealing that the adult brain retains far more capacity for structural change than previously assumed.
Separating well-established findings from the speculative claims that have flooded the wellness industry.
DeepMind's latest model predicts interactions between proteins and small molecules with unprecedented accuracy.
The first approved CRISPR therapies are now being administered. The results are cautiously extraordinary.
Continuous glucose, HRV, and cortisol monitoring are converging into devices that actually change behavior.
Ego depletion research has had a replication crisis. What survived is still highly actionable.
After hundreds of trials, what does the evidence actually support for intermittent fasting?
Every Sunday — five reads worth your time, one insight worth keeping. No filler, no sponsored content.